SignalXSignalX

Baxter International (BAX) 8-K Current Report: March 16, 2026

Filed: March 16, 2026
Health Care
Surgical & Medical Instruments & Apparatus
Baxter International Overview

Baxter International (BAX) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

  • Item 5.02: Departure/Election of Directors or Officers
  • Item 7.01: Regulation FD Disclosure

Baxter International 8-K Mar 16, 2026 Event Analysis

Item 5.02 · Departure/Election of Directors or Officers

  • • CFO Joel Grade out effective March 16, 2026; transitions to advisory role through April 30, 2026 with involuntary-termination severance under Executive Severance Plan
  • • Anita Zielinski, SVP & Chief Accounting Officer, named interim CFO while permanent search underway — dual-role adds execution risk during ongoing restructuring
  • • Zielinski compensation: $50,000/month interim premium plus one-time $250,000 RSU award vesting at 3-year anniversary
  • • Zielinski background: 7 years at Sysco (CFO, US Foodservice Operations; CAO), 20+ years at Ernst & Young as audit partner — strong accounting/finance credentials
  • • CFO departure adds leadership uncertainty at BAX amid active business transformation; permanent search timeline undisclosed

Item 7.01 · Regulation FD Disclosure

  • • Baxter filed a Reg FD disclosure (Item 7.01), meaning material non-public information is being simultaneously released to all investors
  • • Filing explicitly structured as "not filed" under Exchange Act Section 18 — limits shareholder litigation liability for the disclosed content
  • • Actual disclosed material resides in an accompanying exhibit; investors should review Exhibit for substantive operational or financial details

Other Baxter International 8-K Filings

8-K Mar 19, 2026

Get deeper insights on Baxter International

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.